FDA Investigator Rochelle L Cross
Rochelle L Cross has conducted inspections on 34 sites in 10 countries as of 13 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
34
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China,
Canada,
France,
India,
Ireland,
United States of America,
Finland,
Belgium,
Germany,
Switzerland
FDA Investigators that have inspected at least one site in common with Rochelle L Cross:
Alan P Kurtzberg,
Alanna L Mussawwir Bias,
Alicia M Mozzachio,
Amy M Cramer,
Anastasia M Shields,
Angela E Glenn,
Anna Lazar,
Anthony A Charity,
Arsen Karapetyan,
Ashar P Parikh,
Azeezat M Lawal,
Azza Talaat,
Barbara Jwilimczyk Macri,
Barry Rothman,
Bonita S Chester,
Carrie A Hughes,
CDR Ileana Barreto Pettit,
Charisse K Green,
Charles M Edwards,
Charles R Cote, RIC,
Christian F Gomez Lugo,
Christina K Theodorou,
Christine W Twohy,
Concepcion Cruz, Jr,
Daniel J Grabicki,
Daniel J Roberts,
David A Oluwo,
Dell S Moller,
Devon Jenkins,
Djamila Harouaka,
Douglas C Kovacs,
Dr. Robert C Horan, MD,
Dr. S Nar Ali, PhD,
Edwin Martinez,
Elizabeth D Connell,
Emest F Bizjak,
Eric L Dong, BS,
Erika V Butler,
Farhana Khan,
Francis A Guidry,
Frederick F Razzaghi,
Gam S Zamil,
Gayle S Lawson,
Grace E Mcnally,
Gwyn G Dickinson,
Hung H Do, MS,
Ivis L Negron,
Jacob M Dyer,
James P Mcreavey,
John A Gonzalez,
Jonah S Ufferfilge,
Jonathan G Matrisciano,
Jorge L Guadalupe,
Jose A Lopez,
Jose Acruz Gonzalez,
José E Meléndez,
Joseph F Mcginnis, RPh,
Joseph L Despins, PhD,
Joy Rkozlowski Klena,
Justine Tomasso,
Karen E D'orazio,
Karen Takahashi,
Katherine Szestypalow,
Kathryn E Ogger,
Kelli F Dobilas,
Kellia N Hicks,
Kenneth H Williams,
Kent C Faul,
Kevin P Foley,
Kham Phommachanh,
Kimberley A Hoefen,
Kristy A Zielny,
Krystyna M Kitson,
Larry K Austin,
Lata C Mathew, PhD,
Latorie S Jones,
Lawrence Harmon, Jr,
LCDR Debra Emerson,
Liatte Kreuger, PharmD,
Lisa L Flores,
Loretta Nemchik,
Lori M Newman,
Luella J Rossi,
Luis A Dasta,
Marcelo O Mangalindan, Jr,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Marie A Fadden,
Mary E Storch,
Michael R Goga,
Michele L Obert,
Michele Perry Williams,
Miguel A Martinez Perez,
Monica M Mcclure,
Mra Davism,
Mra Mcculloughj,
Nadeem I Chaudhry,
Nancy M Espinal,
Nicholas L Hunt,
Nicholas L Paulin,
Nicole E Knowlton,
Niketa Patel,
Noreen Muñiz,
Pankaj H Amin,
Parul M Patel,
Patrick C Klotzbuecher,
Patsy J Domingo,
Patty P Kaewussdangkul,
Paul A Bonneau,
Paul L Bellamy,
Peter C Chow,
Peter E Baker,
Pratik S Upadhyay, DDC,
Qin Xu,
Rajiv R Srivastava,
Ralph A Erickson,
Ralph H Vocque,
Raquel Gonzalez Rivera,
Reba A Gates,
Rebecca Rodriguez,
Regina T Brown,
Richard E Needham,
Richard L Rutherford,
Robert J Martin,
Rochelle L Campbell,
Roger F Zabinski,
Rosario D'costa,
Russell J Glapion,
Samuel T Walker,
Santos E Camara,
Sarah E Mcmullen,
Satheesh Thomas,
Scott T Ballard,
Sean R Marcsisin,
Sharon K Thoma, PharmD,
Simone E Pitts,
Sneha S Patel,
Stephen D Brown,
Steven A Gonzales,
Steven D Kehoe,
Steven M Weinman,
Susan W Ting,
Susanna E Ford,
Syed N Ali,
Taichun Qin, PhD,
Tamil Arasu, PhD,
Tara G Bizjak,
Tara R Gooen,
Temar Q Williams,
Tina M Pawlowski,
Unnee Ranjan,
William A Warnick,
William D Tingley,
Yasamin Ameri,
Yoriann M Cabrera Bartolomei,
Yumi J Hiramine,
Yvesna C Blaise,
Yvette I Henry,
Yvette I Johnson,
Yvins Dezan,
Yvonne C Mcknight,
Yvonne E Lozano,
Zachary A Bogorad
Rochelle L Cross's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| October, 2020 | FDA 483 | Patricia Kropf MD - Form 483, 2020-11-13 |
| November, 2003 | FDA 483 | Complete Analysis Laboratories Inc - Form 483, 2003-11-21 |
| March, 2018 | FDA 483 | Giacomina Massaro-Giordano M.D. - Form 483, 2018-03-09 |
| November, 2003 | EIR | Complete Analysis Laboratories Inc - EIR, 2003-11-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more